Showing 1 - 8 of 8 Bincy Abraham
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Status: Open Not Enrolling

Investigator: Bincy Abraham

Study Coordinator:

Phone:

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label. ... Read more >

A randomized, double-blind, placebo controlled, dosefinding study to assess the efficacy and safety of SAR443122 in adult patients with moderate to severe ulcerative colitis

Status: Open Not Enrolling

Investigator: Bincy Abraham

Study Coordinator: Melissa Whipple

Phone: 713.441.3247

This is a randomized, double-blind, placebo controlled, dose-ranging Phase 2 study. The primary objective is to evaluate the efficacy and safety of SAR443122 compared to placebo in participants with moderate to severe UC. Dose selection for furt ... Read more >

ABTECT - Maintenance

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Melissa Whipple

Phone: 713.441.3247

This is a multicenter, randomized study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with moderately to severely active ulcerative colitis who have inadequa ... Read more >

ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Melissa Whipple

Phone: 713.441.3247

This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinical remission in subjects with moderately to severely active ulcerative colitis who have inadequat ... Read more >

An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Melissa Whipple

Phone: 713.441.3247

The purpose of this study is to explore the safety, efficacy, effects on quality of life (QOL), and biomarker response of ozanimod in participants with moderate to severely active ulcerative colitis (UC) in clinical practice. ... Read more >

Corrona Inflammatory Bowel Disease (IBD) Registry

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Mayyadah Al-Sabbagh

Phone: 346.238.0024

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Second ... Read more >

Effi cacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease (ENHANCE-CD)

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Melissa Whipple

Phone: 713.441.3247

This study has 3 treatment phases, a 12-Week Induction Phase, a 40-Week Maintenance Phase, and a 48-Week Extension Phase. The objective is to evaluate the efficacy and safety of obefazimod compared to placebo as induction and maintenance th ... Read more >

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Melissa Whipple

Phone: 713.441.3247

Transmural healing (TMH) is recognized as a potentially important measure of Crohn's disease (CD) activity but not a formal target. Observational studies suggest that TMH may be associated with better long-term outcomes. The study will evaluate ... Read more >